Feed COSM
CO

Cosmos Holdings Inc.

COSM · NASDAQ

$0.25 -0.47% (-$0.00)
1M +22.81%
Market Cap $13.8M
P/E Ratio -
Div. Yield -
ROE 118.89%

Bulios Fair Price

$0.38

49.8% upside

Trenutna cena

$0.25

Podcenjeno Poštena vrednost Precenjeno

Po podatkih Bulios Fair Price je delnica COSM trenutno podcenjena glede na svojo tržno ceno. Kako deluje?

Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?

Piotroski F-Score Moderate
4/9
Valuation
100 /100
Cheap
P/S 0.19x
P/B 0.67x
P/E N/A
Growth
49 /100
Stable
Rev. growth 9.04%
Book val. growth 22.55%
EPS growth N/A
Profitability
1 /100
Weak
Gross margin 10.27%
Net margin 33.08%
Op. margin 24.65%
Quality
15 /100
Poor
ROIC 59.82%
ROE 118.89%
ROA 39.68%
Debt
54 /100
Moderate
Debt/Equity 0.35x
Current ratio 1.05x
Int. coverage -8.35x
Stability
50 /100
Moderate
Beta 4.17x
Rev. volatility 9.42%
EPS volatility 27.51%

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o COSM
Online

O podjetju

Cosmos Holdings Inc. is a pharmaceutical company focused on the distribution and sale of generic pharmaceuticals, OTC (over-the-counter) products, and medical devices. The company's distribution network covers over 40 countries worldwide, enabling it to reach a global market. Cosmos Holdings aims to provide affordable and high-quality pharmaceuticals that meet the needs of customers in over twenty therapeutic areas. The company also actively seeks new opportunities to develop and grow its product portfolio. Shares of Cosmos Holdings Inc. may be appealing to investors seeking investment opportunities in the pharmaceutical sector with a global reach and diversified product portfolio.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Medical - Pharmaceuticals

CEO

Grigorios Siokas

Employees

163

Headquarters

Thessaloniki

Prihajajoči dogodki

13 NOV.

Earnings

Upcoming earnings report

62d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.